October 1, 2020 - Guidepost Solutions announces the hiring of Susannah Herkert as senior director. Susannah is a nationally recognized expert in the area of pharmaceutical controlled substance investigations and regulatory compliance who served with the Drug Enforcement Administration for more than 15 years.
“Susannah essentially wrote the book used to train DEA personnel to successfully investigate violators of the Controlled Substances Act,” said Julie Myers Wood, CEO, Guidepost Solutions. “Her experience includes investigating complex criminal and civil conspiracy cases involving the illicit distribution of controlled substances by practitioners, pharmacies, and distributors. Susannah will be a great asset to DEA registrants in all areas of the closed-system of distribution.”
Ms. Herkert began her career with DEA in the Los Angeles Field Division where she was a Diversion Investigator on the Tactical Diversion Squad. There, she was the lead investigator on numerous criminal/civil diversion cases, including national impact cases. In 2010, Ms. Herkert transferred to the Dallas Field Division where she was assigned to the Tactical Diversion Squad. She was the lead investigator on numerous cases resulting in the federal convictions and/or civil fines of physicians, pharmacists, and co-conspirators.
After her success in the field, Ms. Herkert transferred to Quantico where she was the first Unit Chief for the Diversion Specialized Training Unit. She developed and instructed over a dozen courses ranging from Red Flags in Diversion Investigations to Corresponding Responsibility to Charging Corporations. Ms. Herkert developed a criminal/civil investigation model that has been implemented by DEA investigators nationwide. While at Quantico, she was also the Acting Unit Chief for the Diversion Training Unit, which instructed all incoming DEA Diversion Investigators during a 12-week in-service accredited program.
Ms. Herkert has testified as an expert in diversion investigations in federal judicial districts throughout the United States and is a sought-out speaker on pharmaceutical trends and investigations.